Yingying Chen
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Yingying Chen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Other | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yingying Chen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stony Brook University | College/University | Undergraduate Degree | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Johnson Graduate School of Management | College/University | Masters Business Admin | |
University of North Carolina System | College/University | Doctorate Degree | |
Hbm Suzhou Co. Ltd. | Corporate Officer/Principal | ||
ALPHAMAB ONCOLOGY | Biotechnology | Director of Finance/CFO | |
Columbia Business School | College/University | Graduate Degree | |
Lansdowne Partners (UK) LLP
Lansdowne Partners (UK) LLP Investment ManagersFinance Lansdowne Partners (UK) LLP (Lansdowne) is the alternative investment management subsidiary of Lansdowne Partners Ltd., itself a subsidiary of Lansdowne Partners International Ltd. in the Cayman Islands. The firm is headquartered in London and was founded in 1998. Lansdowne provides investment advisory services on a discretionary basis to their clients, which includes commingled investment vehicles intended for institutional investors and other sophisticated investors and investment vehicles formed for particular investors and separately managed accounts for sophisticated financial institutions, including registered investment companies. Lansdowne is a signatory to the United Nations Principles of Responsible Investing (UNPRI). | Investment Managers | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree | |
The Permal Group Ltd.
The Permal Group Ltd. Investment Trusts/Mutual FundsMiscellaneous The Permal Group Ltd. provides asset management services. It offers multi-manager and single manager funds, separate accounts and structured products. The company is headquartered in New York, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Matthews International Capital Management LLC
Matthews International Capital Management LLC Investment ManagersFinance Matthews International Capital Management LLC (dba Matthews Asia) is an independent SEC-registered investment advisor and mutual fund manager headquartered in San Francisco, California. The firm was founded by Paul Matthews in 1991. Matthews Asia manages portfolios for institutional clients, pension and profit-sharing plans, insurance companies, endowments and foundations and other business entities around the world. Institutional clients include funds registered under the laws of Luxembourg, United Kingdom, Ireland and Canada. | Investment Managers | Corporate Officer/Principal | |
MEDICENNA THERAPEUTICS CORP. | Biotechnology | Chief Tech/Sci/R&D Officer | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
Brandeis University | College/University | Graduate Degree | |
Nanjing Medical University | College/University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 14 |
China | 5 |
Vereinigtes Königreich | 3 |
Kanada | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 8 |
Finance | 3 |
Miscellaneous | 2 |
Health Services | 2 |
Operativ
Corporate Officer/Principal | 12 |
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 3 |
Graduate Degree | 3 |
Director of Finance/CFO | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Humphrey Gardner | 9 |
Weihao Xu | 8 |
Mai Jing Liao | 6 |
Xiao Xiang Chen | 2 |
- Börse
- Insiders
- Yingying Chen
- Unternehmensverbindungen